76.5 (brd, J = 10.5 Hz), 109.3, 115.5 (d, J = 10.5 Hz), 115.8 (d,
J = 10.5 Hz), 118.1, 122.8 (d, J = 9.5 Hz), 123.1 (d, J = 9.5 Hz),
129.6 (d, J = 14.3 Hz), 129.8 (d, J = 14.3 Hz), 134.0 (d, J =
99.2 Hz), 134.5 (d, J = 99.2 Hz), 159.5 (d, J = 10.5 Hz), 159.6
(d, J = 10.5 Hz); 31P{1H} NMR (162 MHz, CDCl3) δ 29.7;
LR-FABMS (CHCl3 + NBA) m/z 651 (M + H+, 61), 593 (M +
H+ − Me2CO, 17), 331 (M + H+ − Me2CO − Ar2POH, 31), 261
(Ar2PO+, 100); HR-FABMS (CHCl3 + NBA) m/z calcd for
C35H41O8P2 (M + H+) 651.2277, found 651.2294.
7.09 (d, J = 3.7 Hz, 4H), 7.37 (dd, J = 11.7, 2.5 Hz, 8H); 13C
NMR (100 MHz, CDCl3) δ 21.3, 26.9, 33.2 (d, J = 70.6 Hz),
76.6 (d, J = 10.5 Hz), 109.2, 128.3 (d, J = 9.5 Hz), 128.7 (d, J =
9.5 Hz), 132.7 (d, J = 99.2 Hz), 133.20 (d, J = 99.2 Hz), 133.25
(d, J = 1.9 Hz), 133.4 (d, J = 1.9 Hz), 137.9 (d, J = 12.4 Hz),
138.2 (d, J = 12.4 Hz); 31P{1H} NMR (162 MHz, CDCl3) δ
29.8; LR-FABMS (CHCl3 + NBA) m/z 643 (M + H+, 74), 585
(M + H+ − Me2CO, 13), 327 (M + H+ − Me2CO − Ar2POH,
18), 257 (Ar2PO+, 100); HR-FABMS (CHCl3 + NBA) m/z calcd
for C39H49O4P2 (M + H+) 643.3106, found 643.3124.
(R,R)-m-Cl-DIOPO (1f)
(R,R)-Thienyl-DIOPO (1i)
TLC: Rf 0.71 (AcOEt–EtOH = 10 : 1, stained blue with phospho-
molybdic acid–EtOH); mp 72–74 °C; [α]1D7 +14.8 (c 1.03,
CHCl3); IR (KBr, cm−1) 1566, 1469, 1403, 1186, 1134, 685;
1H-NMR (400 MHz, CDCl3) δ 1.20 (s, 6H), 2.64 (ddd, J = 15.1,
9.2, 6.9 Hz, 2H), 2.76 (ddd, J = 15.1, 14.7, 4.1 Hz, 2H),
4.10–4.22 (m, 2H), 7.43 (dddd, J = 8.2, 7.8, 3.4, 2.3 Hz, 4H),
7.51 (brd, J = 8.2 Hz, 4H), 7.63 (dd, J = 11.0, 7.8 Hz, 4H), 7.78
(brd, J = 11.9 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 26.7,
32.8 (d, J = 71.5 Hz), 76.1 (d, J = 10.5 Hz), 109.7, 128.6 (d, J =
9.5 Hz), 129.0 (d, J = 9.5 Hz), 130.1 (d, J = 12.4 Hz), 130.3 (d,
J = 13.4 Hz), 130.6 (d, J = 10.5 Hz), 131.1 (d, J = 10.5 Hz),
132.2 (d, J = 2.9 Hz), 132.3 (d, J = 1.9 Hz), 134.4 (d, J = 98.2
Hz), 135.0 (d, J = 99.2 Hz), 135.1 (d, J = 15.3 Hz), 135.3 (d, J
= 16.2 Hz); 31P{1H} NMR (162 MHz, CDCl3) δ 27.8;
LR-FABMS (CHCl3 + NBA) m/z 667 (M + H+, 34), 609 (M +
H+ − Me2CO, 23), 339 (M + H+ − Me2CO − Ar2POH, 54), 269
(Ar2PO+, 100); HR-FABMS (CHCl3 + NBA) m/z calcd for
C31H29Cl4O4P2 (M + H+) 667.0295, found 667.0325.
TLC: Rf 0.57 (AcOEt–EtOH = 10 : 1, stained blue with phospho-
molybdic acid–EtOH); mp 171–173 °C; [α]2D8 +3.2 (c 1.01,
CHCl3); IR (KBr, cm−1) 1502, 1406, 1188, 1176, 1095, 1016,
714, 536; 1H-NMR (400 MHz, CDCl3) δ 1.26 (s, 6H), 2.66
(ddd, J = 15.1, 10.1, 6.9 Hz, 2H), 2.86 (ddd, J = 15.1, 14.7, 4.6
Hz, 2H), 4.17–4.27 (m, 2H), 7.17–7.20 (m, 4H), 7.63–7.68 (m,
4H), 7.70–7.74 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 26.8,
37.0 (d, J = 79.1 Hz), 76.2 (d, J = 11.4 Hz), 109.6, 128.2 (d, J =
11.4 Hz), 128.4 (d, J = 10.5 Hz), 133.50 (d, J = 4.8 Hz), 133.58
(d, J = 4.6 Hz), 133.64 (d, J = 114.4 Hz), 134.2 (d, J = 114.4
Hz), 135.6 (d, J = 9.5 Hz), 135.9 (d, J = 10.5 Hz); 31P{1H}
NMR (162 MHz, CDCl3) δ 18.8; LR-FABMS (CHCl3 + NBA)
m/z 555 (M + H+, 99), 497 (M + H+ − Me2CO, 18), 283 (M +
H+ − Me2CO − Ar2POH, 24), 213 (Ar2PO+, 100); HR-FABMS
(CHCl3 + NBA) m/z calcd for C23H25O4P2S4 (M + H+)
555.0111, found 555.0107.
(R,R)-DMPP-DIOPO (1j)
(R,R)-o-Tolyl-DIOPO (1g)
TLC: Rf 0.23 (AcOEt–EtOH = 10 : 1, stained blue with phospho-
molybdic acid–EtOH); mp 120–124 °C; [α]2D0 −21.0 (c 1.00,
CHCl3); IR (KBr, cm−1) 2981, 1612, 1587, 1473, 1396, 1281,
TLC: Rf 0.71 (AcOEt–EtOH = 10 : 1, stained blue with phospho-
molybdic acid–EtOH); mp 61–63 °C; [α]2D8 −4.0 (c 0.98,
CHCl3); IR (KBr, cm−1) 1593, 1453, 1178, 750; 1H-NMR
(400 MHz, CDCl3) δ 1.15 (s, 6H), 2.30 (s, 12H), 2.67–2.77 (m,
4H), 4.20–4.30 (m, 2H), 7.12–7.20 (m, 4H), 7.20–7.30 (m, 4H),
7.33–7.42 (m, 4H), 7.71 (dd, J = 12.8, 7.8 Hz, 2H), 7.84 (dd, J
= 13.3, 7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 21.3, 26.7,
31.9 (d, J = 71.5 Hz), 76.2 (dd, J = 11.9, 3.3 Hz), 109.0, 125.3
(d, J = 12.4 Hz), 125.6 (d, J = 11.5 Hz), 131.2 (d, J = 97.3 Hz),
131.5 (d, J = 10.5 Hz), 131.63, 131.66 (d, J = 10.5 Hz), 131.7,
131.8 (d, J = 10.5 Hz), 132.0 (d, J = 97.3 Hz), 132.4 (d, J =
10.5 Hz), 141.3 (d, J = 8.6 Hz), 141.7 (d, J = 9.5 Hz); 31P{1H}
NMR (162 MHz, CDCl3) δ 31.8; LR-FABMS (CHCl3 + NBA)
m/z 587 (M + H+, 100), 529 (M + H+ − Me2CO, 13), 299 (M +
H+ − Me2CO − Ar2POH, 24), 229 (Ar2PO+, 90); HR-FABMS
(CHCl3 + NBA) m/z calcd for C35H41O4P2 (M + H+) 587.2480,
found 587.2465.
1
1230, 1163, 822, 762; H-NMR (400 MHz, CDCl3) δ 1.03 (s,
6H), 2.07–2.12 (ddd, J = 15.1, 9.6, 9.6 Hz, 2H), 2.31 (ddd, J =
16.1, 15.1, 2.8 Hz, 2H), 2.37 (s, 6H), 2.39 (s, 6H), 3.70–3.80
(m, 2H), 7.12 (ddd, J = 8.2, 6.4, 2.3 Hz, 4H), 7.35 (ddd, J = 8.4,
4.1, 2.1 Hz, 4H), 7.72 (brd, J = 13.3 Hz, 2H), 7.77 (dd, J = 13.3
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 20.6, 26.6, 37.2 (d, J =
79.1 Hz), 76.3 (dd, J = 14.3, 4.8 Hz), 109.1, 113.6 (d, J = 99.2
Hz), 114.4 (d, J = 99.2 Hz), 117.73 (d, J = 5.7 Hz), 117.79 (d, J
= 5.7 Hz), 130.0 (d, J = 3.8 Hz), 131.1 (d, J = 3.8 Hz), 133.1 (d,
J = 10.5 Hz), 133.4 (d, J = 10.5 Hz), 134.7, 153.22 (d, J = 3.8
Hz), 153.31 (d, J = 3.8 Hz); 31P{1H} NMR (162 MHz, CDCl3)
δ 5.2; LR-FABMS (CHCl3 + NBA) m/z 615 (M + H+, 75), 557
(M + H+ − Me2CO, 9), 313 (M + H+ − Me2CO − Ar2POH, 12),
243 (Ar2PO+, 100); HR-FABMS (CHCl3 + NBA) m/z calcd for
C35H37O6P2 (M + H+) 615.2065, found 615.2067.
(R,R)-m-Xylyl-DIOPO (1h)
General procedure for reductive aldol reaction of chalcone and
aldehydes catalyzed by Ar-DIOPO
TLC: Rf 0.71 (AcOEt–EtOH = 10 : 1, stained blue with phospho-
molybdic acid–EtOH); mp 156–158 °C; [α]2D7 +24.8 (c 1.00,
CHCl3); IR (KBr, cm−1) 1601, 1454, 1419, 1377, 1273, 1182,
To a solution of Ar-DIOPO (10 mol%), chalcone (0.25 mmol)
and an aldehyde (0.3 mmol, 1.2 equiv) in dry propionitrile
(2 mL) was added dropwise trichlorosilane (ca. 3 M CH2Cl2 sol-
ution, 0.5 mmol) at −78 °C. The mixture was stirred for the
1
1128, 1043, 852, 694, 571; H-NMR (400 MHz, CDCl3) δ 1.22
(s, 6H), 2.31 (s, 24H), 2.50–2.67 (m, 4H), 4.08–4.16 (m, 2H),
4568 | Org. Biomol. Chem., 2012, 10, 4562–4570
This journal is © The Royal Society of Chemistry 2012